You are about to leave the Clinical Value website now.

Cancel

LEAD Perspective: Evaluating GAAD – A Malaysian Multicentre Study

Prof Chan Wah Keong

LEAD Perspective: The Taiwan Liver Story – Hepatitis Elimination and HCC Surveillance

Prof Yi-Hsiang Huang

Prof Yi-Hsiang Huang shares the Taiwan Liver Story – Expert Insights from LEAD 2025, the leading APAC Liver Disease Expert Meeting This is a verbatim transcript of an interview conducted with Prof Yi-Hsiang Huang in June 2025. The transcript has been lightly edited for clarity. Introduction I’m Yi-Hsiang Huang, the president of Taiwan Liver Cancer Association and now the hepatologist…

LEAD Perspective: Asia Pacific Consensus Statement on the clinical and economic utility of biomarker-based algorithms in the early detection and surveillance of HCC

Prof Teera

LEAD Perspective: Taiwan’s Liver Disease Patients – From Chronic Hepatitis to Cancer Care

Dr Yang Pei-Ming

Dr Pei-Ming Yang discusses Taiwan’s Liver Disease landscape, from Chronic Hepatitis to cancer care – Expert Insights from LEAD 2025, the leading APAC Liver Disease Expert Meeting   The following is a verbatim transcript of an interview conducted with Dr Pei-Ming Yang in June 2025. The transcript has been lightly edited for clarity. Introduction I am Dr Pei-Ming Yang, currently…

Screening for Liver Cancer at Zhuhai People’s Hospital

Dr-Bing-Liu-featured-image

Current Trends in Liver Fibrosis Etiology and Diagnosis

Prof Jacob George featured image